HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Givaudan Strikes Deal For Amyris Ingredients, Long-Term Partnership

Executive Summary

The deal has Amyris selling three key cosmetic ingredients to Givaudan and producing more biotech ingredients for the Swiss firm over the long term. “In the future, we will continue to push the boundaries of biotech, creating new sustainable innovations for a better beauty future,” says Givaudan’s Maurizio Volpi, president, Fragrance and Beauty.

You may also be interested in...

Firmenich, IFF Tout Eco-Fragrance Design Tools; Inter Parfums’ Sales Soar In Q4; Fragrance Sales & Sustainability News

Firmenich and International Flavors & Fragrances’ LRM Naturals announce developments to better support customers’ sustainable product development and transparency needs. Givaudan, Symrise and Inter Parfums report strong results in fiscal 2022, fueled by unleashed fragrance demand around the globe.

Biotech Amyris: ‘We Have Built The Fastest-Growing Consumer Business In Health, Beauty And Wellness’

Emeryville, CA-based Amyris launches the Stripes menopause care line with actress Naomi Watts, as well as Gen Z-targeted EcoFabulous skin care and cosmetics, acquired last year. The biotech projects its burgeoning Consumer business will grow more than 150% in 2022.

Biotech Amyris Targeting 150% Consumer Biz Growth In 2022, Up To 40% In Ingredients Arm

The Emeryville, CA-based synthetic biotech firm projects big growth in 2022 as customers seek out “the purest, cleanest and most sustainably sourced natural ingredients in the world.” Amyris’ business is split between Technology Access and Consumer, the latter set to more than double this year.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts